<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00944203</url>
  </required_header>
  <id_info>
    <org_study_id>TMEC09-031</org_study_id>
    <nct_id>NCT00944203</nct_id>
  </id_info>
  <brief_title>Efficacy of Ipomea Pes-caprae Ointment as an add-on Therapy in Patient With Jellyfish Dermatitis</brief_title>
  <official_title>Efficacy of Ipomea Pes-caprae Ointment as an add-on Therapy in Patient With Jellyfish Dermatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mahidol University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mahidol University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an open label, prospective, test of superiority efficacy trial of Ipomea pes-caprae
      ointment as an add-on therapy in patient with jellyfish dermatitis. Each patient will receive
      standard medical treatment depend on the severity of the disease. The doctor will divide the
      dermatitis area of each patient into two parts. Ipomea pes-caprae ointment will be applied as
      an add-on therapy to the &quot;test area&quot;, while the ointment will not be applied to the &quot;control
      area&quot;. Patients will be asked to come for follow up 6 times in the 28-days study period.
      Primary objective is to compare the healing time of dermatitis in both areas.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The &quot;Test area&quot; and &quot;Control area&quot; are allocated in each participant. We use the Internal
      Control fashion. The healing time of each area will be collected as an outcome measure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Healing time of the Jellyfish dermatitis lesion (days)</measure>
    <time_frame>Follow up to 28 days</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Jellyfish Dermatitis</condition>
  <condition>Jellyfish Venoms</condition>
  <arm_group>
    <arm_group_label>Test Area</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test Area = Standard Treatment plus Ipomea pes-caprae oinment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Area</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control = Standard Treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ipomea pes-caprae ointment</intervention_name>
    <description>Ipomea pes-caprae ointment will be applied twice a day as an add-on therapy.</description>
    <arm_group_label>Test Area</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of jellyfish dermatitis

          -  total lesion area is more than 4 square centimeter

        Exclusion Criteria:

          -  expose to jellyfish more than 7 days

          -  severe systemic reaction to jellyfish

          -  allergy to Ipomea pes-caprae or the component of the ointments
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Watcharapong Piyaphanee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mahidol University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital for Tropical Diseases, Faculty of Tropical Medicine, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10400</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 22, 2009</study_first_submitted>
  <study_first_submitted_qc>July 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 23, 2009</study_first_posted>
  <last_update_submitted>March 20, 2018</last_update_submitted>
  <last_update_submitted_qc>March 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mahidol University</investigator_affiliation>
    <investigator_full_name>Watcharapong Piyaphanee</investigator_full_name>
    <investigator_title>Doctor</investigator_title>
  </responsible_party>
  <keyword>jellyfish</keyword>
  <keyword>jellyfish venom</keyword>
  <keyword>jellyfish dermatitis</keyword>
  <keyword>jellyfish stings</keyword>
  <keyword>Ipomea pes-caprae</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dermatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

